Dual Sustained Release Matrix

in this video you discover how dual matrix containing two sustained release(SR) agents, Compritol® 888 ATO and HPMC enables the production of robust SR tablets.

Microfluidic preparation and optimization of Kollicoat ® IR-b-PCL polymersome for co-delivery of Nisin-Curcumin in breast cancer application

Labrafac MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies

Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability

With dual matrix, you can:

reduce the SR agent concentration
reduce the alcohol quantity used in wet granulation process
reduce drug release variability
achieve high drug dose tablet by direct compression

Discover Gattefossé range of excipients to sustain drug release.

excipients